Study on the precancerous gastric mucosa using gastrin-overexpressing transgenic mice
Study on the precancerous gastric mucosa using gastrin-overexpressing transgenic mice
批准号:
06454255
负责人:
TAKEUCHI Toshiyuki
金额:
$4.48万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hypergastrinemia is frequently observed in patients with Zollinger-Ellison (ZE) tumor and with atrophic gastritis. ZE tumor is known to produce a high level of gastrin, which stimulates parietal cells and enterochromaffin-like (ECL) cells, both of which are known to express a gastrin receptor. Upon gastrin stimulation parietal cells produce gastric acid, and ECL cells produce histamine, a potent acid secretagogue on parietal cells. With a synergistic effect of gastrin and histamine, parietal cells produce a plentiful of gastric acid, and gastric mucosa becomes hypertrophic by yet unknown mechanisms. Another cause of hypergastrinemia is atrophic gastritis that is known as a precancerous state. In atrophic gastritis, gastric fluid becomes neutral due to deficiency of gastric acid because parietal cells are often impaired by autoimmune mechanisms or toxins from Helicobacter pylori. Resultantly, gastrin production is up-regulated from antral G cells by the lack of an inhibitory message, ac … More idity in gastric fluid.To elucidate the mechanism of hypertrophic growth of gastric mucosa by gastrin and TGFalpha, We attempted to produce transgenic mice with overexpression of gastrin or TGFalpha in gastric mucosa. Fortunately, co-investigator, H.Takagi, has already made transgenic mice with overexpressing TGFalpha in the gastric mucosa before. Thus, we focused on the production of gastrin-overexpressing transgenic mice. Gastrin is synthesized as a precursor preprogastrin. This precursor requires a series of post-translational processing reactions to become bioactive gastrin, which include dibasic cleavage at paired basic residues, their subsequent removal by carboxypeptidase H,and formation of a carboxyl (C-) terminal amide moiety via the action of the amidation enzyme, peptidyl-glycine alpha-amidating mono-oxygenase (PAM). The amidated gastrin (G17-NH_2) thus formed, exhibits gastric acid-secreting activity three orders of magnitude higher than does glycine-extended a gastrin (G17-Gly). To attain hypergastrinemia in tansgenic mice, we expressed a gastrin cDNA under the control of a beta-actin promoter, which exhibits strong expression in a variety of tissues. Another devise we used is the cleavage site for proprotein-processing enzyme furin, which distributes in virtually all tissues. By creating a furin creavable site before gastrin-17 and deleting the C-terminal extension peptide to become glycine as a last amino acid for efficient amidation reaction, we succeeded in producing bioactive gastrin from two conventional culture cell lines CHO and COS-7. Then, we injected the gastrin expression uint DNA into a rat ovum for producing transgenic mice. We obtained five hypergastrinemic mice with 400-500 pg/ml serum gastrin. By cross-mating these heterozygous mice, we obtained homozygous mice with a 600-1500 pg/ml serum gastrin level. As expected, hypergastrinemic mice had hypertrophic gastric mucosa with an extended hight of a surface mucous cell layr along a gastric pit. Although a gastric gland unit is highly extended, its structure was normally arranged and surface mucous cells appear to be normal. In contrast, TGFalpha-overexpressing gastric mucosa exhibited enlarged mucous epithelia with hyperplastic, dysplastic and cystic changes. Gastric glandular structure was similar to Menetrier's disease in humans, which is a precancerous state for gastric cancer. Since gastrin receptors are localized in parietal cells and ECL cells, the growth of mucosa by gastrin is thought to be mediated by unknown factors from parietal cells. One of the candidates of these factors was TGFalpha. However, considering the difference in histological changes between gastrin and TGFalpha, gastrin appears to exert its asction directly onto gastric surface mucous cells. Our preliminary data suggests that gastric surface mucous cells may express gastrin receptors on their plasma membrane.As expected, hypergastrinemic mice had hypertrophic gastric mucosa with an extended hight of a surface mucous cell layr along a gastric pit. Although a gastric gland unit is highly extended, its structure was normally arranged and surface mucous cells appear to be normal. In contrast, TGFalpha-overexpressing gastric mucosa exhibited enlarged mucous epithelia with hyperplastic, dysplastic and cystic changes. Gastric glandular structure was similar to Menetrier's disease in humans, which is a precancerous state for gastric cancer. Since gastrin receptors are localized in parietal cells and ECL cells, the growth of mucosa by gastrin is thought to be mediated by unknown factors from parietal cells. One of the candidates of these factors was TGFalpha. However, considering the difference in histological changes between gastrin and TGFalpha, gastrin appears to exert its asction directly onto gastric surface mucous cells. Our preliminary data suggests that gastric surface mucous cells may express gastrin receptors on their plasma membrane.Gastrin has long been thought to act as a tumor promoter for gastic cancer. But, our gastrin-overexpressing model dose not support this possibility although TGFalpha appears to be involved in the formation of precancerous changes in the gastric mucosa. Less
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Nishigori, M.Yanagita and T.Takeuchi: "Proinsulin cleaved by furin is processed to chromatographically mature insulin by carboxy-peptidases in non-neuroendocrine cells" Peptides. 17. 789-796 (1996)
T.Nishigori、M.Yanagita 和 T.Takeuchi:“被弗林蛋白酶裂解的胰岛素原在非神经内分泌细胞中通过羧肽酶加工成色谱成熟的胰岛素”肽。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
D.Lu, H.Hoshino, T.Takeuchi: "Regulatable production of mature insulin from a hepatocyte cell line : insulin production is up-regulated by cAMP and glucocorticoids, and down-regulated by Insulin" FEBS Lett.399. 37-42 (1996)
D.Lu、H.Hoshino、T.Takeuchi:“肝细胞系可调节成熟胰岛素的产生:cAMP 和糖皮质激素上调胰岛素产生,胰岛素下调”FEBS Lett.399。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Takahashi, Y.Liu, N.Hayashi, F.Goto, M.Kato, H.Kawashima, T.Takeuchi: "Production of bioactive salmon calcitonin from the nonendocrine cell lines COS-7 and CHO" Peptides. (in press). (1997)
K.Takahashi、Y.Liu、N.Hayashi、F.Goto、M.Kato、H.Kawashima、T.Takeuchi:“从非内分泌细胞系 COS-7 和 CHO 中生产生物活性鲑鱼降钙素”肽。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Kayo,Y.Konda,S.Tanaka,et al.: "Developmental expression of proprotein-processing endoprotease furin in rat pancreatic islets." Endocrinology. 137. 5126-5134 (1996)
T.Kayo、Y.Konda、S.Tanaka 等人:“大鼠胰岛中前蛋白加工内切蛋白酶弗林蛋白酶的发育表达”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Kayo, Y.Sawada, M.Suda, Y.Konda, T.Izumi, S.Tanaka, H.Shibata, T.Takeuchi: "Proteolytic activity of proprotein-processing endoprotease furin controls growth of pancreatic beta cells" Diabetes. (in press). (1997)
T.Kayo、Y.Sawada、M.Suda、Y.Konda、T.Izumi、S.Tanaka、H.Shibata、T.Takeuchi:“前蛋白加工内切蛋白酶弗林蛋白酶的蛋白水解活性控制胰腺 β 细胞的生长”糖尿病。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Study on mitochondrial respiratory chain function using a hypoxia-sensing luminescent iridium complex probe
-
批准号:24651256
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.66万
-
财政年份:2012
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Research and development of hypoxia-detecting luminescent probe iridium complex and its application to endoscopic imaging probes
-
批准号:21300159
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2009
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Expression of highly differentiated functions in gastric mucosal cells by paracrine mechanisms between distinct cell-types and appearance of adherent property to H. pylori in inverse proportion to decline in their differentiated functions
-
批准号:12470118
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:2000
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Studies on insulin secretory granule formation capacity by the control of proprotein-processing endoprotease furin.
-
批准号:09470213
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:1997
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Gene therapy of streptozotocin-induced diabetic rats with a regulatable insulin expression vector
-
批准号:06557051
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$10.69万
-
财政年份:1994
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin in non-endocrine nell lines
-
批准号:04454554
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1992
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Endocrine Cells and its Amidating Capability
-
批准号:01480285
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.26万
-
财政年份:1989
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
Experimental Gene Therapy Utilizing a Skin Transplant
-
批准号:01870103
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$5.95万
-
财政年份:1989
-
负责人:TAKEUCHI Toshiyuki
-
依托单位:
海外基金